Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · Real-Time Price · USD
13.24
-0.02 (-0.15%)
At close: Mar 6, 2026, 4:00 PM EST
13.15
-0.09 (-0.68%)
After-hours: Mar 6, 2026, 7:30 PM EST
Amneal Pharmaceuticals Analyst Ratings
Total Analysts
4
Consensus Rating
Strong Buy
Price Target
$14.75
Upside
+11.40%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Strong Buy Maintains $15 → $17 | Strong Buy | Maintains | $15 → $17 | +28.40% | Mar 2, 2026 |
| Barclays | Barclays | Buy Initiates $15 | Buy | Initiates | $15 | +13.29% | Dec 9, 2025 |
| Piper Sandler | Piper Sandler | Buy Reiterates $11 → $13 | Buy | Reiterates | $11 → $13 | -1.81% | Oct 31, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $12 → $14 | Buy | Maintains | $12 → $14 | +5.74% | Sep 16, 2025 |
| Barclays | Barclays | Buy Maintains $10 → $11 | Buy | Maintains | $10 → $11 | -16.92% | Mar 3, 2025 |
| JP Morgan | JP Morgan | Hold → Buy Upgrades $9 → $12 | Hold → Buy | Upgrades | $9 → $12 | -9.37% | Feb 24, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $9 → $11 | Buy | Maintains | $9 → $11 | -16.92% | Nov 11, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $10 → $12 | Strong Buy | Maintains | $10 → $12 | -9.37% | Oct 2, 2024 |
| JP Morgan | JP Morgan | Sell → Hold Upgrades $9 | Sell → Hold | Upgrades | $9 | -32.02% | Sep 6, 2024 |
| Barclays | Barclays | Buy Maintains $8 → $10 | Buy | Maintains | $8 → $10 | -24.47% | Aug 13, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $9 → $10 | Strong Buy | Maintains | $9 → $10 | -24.47% | Aug 12, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $6.25 → $8 | Strong Buy | Maintains | $6.25 → $8 | -39.58% | May 6, 2024 |
| Truist Securities | Truist Securities | Strong Buy Reiterates $7 → $9 | Strong Buy | Reiterates | $7 → $9 | -32.02% | May 6, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $6 → $8 | Buy | Maintains | $6 → $8 | -39.58% | Mar 21, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $5.5 → $6.25 | Strong Buy | Maintains | $5.5 → $6.25 | -52.79% | Mar 4, 2024 |
| Barclays | Barclays | Buy Maintains $6 → $8 | Buy | Maintains | $6 → $8 | -39.58% | Jan 29, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.